Key result
A review of antithrombotic medications for patients with acute coronary syndromes undergoing percutaneous coronary intervention provides an algorithm to guide clinical decision-making.
This review provides an algorithm to guide the selection of optimal antithrombotic regimens for patients with acute coronary syndromes undergoing PCI based on risk-benefit ratios.
Answers are grounded in this paper and cite their sources.
May guide antithrombotic selection in ACS-PCI; leaves open prospective validation of the algorithm.
The wide variety of anticoagulant and antiplatelet agents available for clinical use has made choosing the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention a complex task. While there is no single best regimen, from a risk-benefit ratio standpoint, particular regimens may be considered optimal for different patients. We review the mechanisms of action for the commonly prescribed antithrombotic medications, summarize pertinent data from randomized trials on their use in acute coronary syndromes, and provide an algorithm (incorporating data from these trials as well as risk assessment instruments) that will help guide the decision-making process.
No takes yet. Share an insight, caveat, or question.
A 2009 study conducted a review in acute coronary syndromes undergoing percutaneous coronary intervention. antithrombotic medications was evaluated. A review of antithrombotic medications for patients with acute coronary syndromes undergoing percutaneous coronary intervention provides an algorithm to guide clinical decision-making.
Synapse has enriched 10 related papers. Consider them for comparative context: